Azenosertib (ZN-c3)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Azenosertib (ZN-c3), covering 2026-03-18 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors [Phase 1]